FDA refuses to review Moderna’s mRNA flu vaccine despite no safety or efficacy concerns, rejecting a clinical trial design the agency itself approved in 2024.
EU, Canada, Australia all accepted application
Read the full story at NBC News
From the February 10, 2026 GovBrief, every story that day in one place.